Report Finder

All Sentinel reports, surveillance tools, FDA assessments, and communication materials may be searched using the options below. Search results can be further sorted by title, project status, and date posted by clicking on the relevant column header. If you wish to search for FDA Center assessments more specifically by medical product and health outcome, please go to the CDER Assessments and CBER Assessments pages.

E.g., 12/13/2019
E.g., 12/13/2019
Title Status FDA Centersort ascending Date Posted
Use of Stents Complete CDRH 01/23/2018
Trends in Fibroid Surgery and Use of Power Morcellation Complete CDRH 12/14/2017
Isoniazid Use Complete CDER 01/07/2013
New Use of Dabigatran or Warfarin and Gastrointestinal Hemorrhage or Intracerebral Hemorrhage Events Complete CDER 06/21/2016
Lupron Depot-PED Use Among Patients with Central Precocious Puberty Complete CDER 04/15/2019
Asthma Diagnoses Complete CDER 04/26/2012
Incident and Prevalent Use of Alvimopan, Naltrexone, and Methylnaltrexone In progress CDER 11/23/2014
Use of Clonazepam Complete CDER 03/26/2018
Occurrence of Kidney Stones Complete CDER 02/25/2014
Anti-Infective Agents Use Complete CDER 09/14/2013
Boceprevir and Telaprevir Use Complete CDER 01/07/2013
New Use of Anti-Epileptic Drugs and Agranulocytosis Complete CDER 06/21/2016
Duration of Use Among New Users of Hydrochlorothiazide (HCTZ), Angiotensin-Converting Enzyme Inhibitors (ACEIs), and Angiotensin II Receptor Blockers (ARBs) Complete CDER 04/19/2019
Acute Myocardial Infarction Diagnoses Complete CDER 04/25/2012
Methotrexate and Tofacitinib Use In progress CDER 11/24/2014
Risk of Acute Myocardial Infarction and Stroke among Carbidopa/Levodopa, Entacapone, and Carbidopa/Levodopa/Entacapone Users Complete CDER 03/27/2018
PROMPT: Mirabegron Surveillance Discontinued CDER 09/21/2016
Molecularly Targeted Anti-Cancer Therapies Complete CDER 01/24/2018
Cardiovascular Therapy Agents Use Complete CDER 09/14/2013
Alosetron Use In progress CDER 10/11/2017
Injection Amphotericin Procedures Complete CDER 01/07/2013
IVIg Product Use and Hemolysis Events Complete CDER 06/03/2016
Neuropsychiatric Events following Montelukast Use Complete CDER 04/22/2019
Milk Allergy Diagnoses Complete CDER 05/11/2012
Gastrointestinal Disorders Complete CDER 02/25/2015
Prevalent and Incident Use of Fingolimod Complete CDER 03/28/2018
Characterization of Pediatric Medical Conditions: Respiratory Syncytial Virus (RSV) Associated Illness Complete CDER 01/25/2018
Gastrointestinal Therapy Agents Use Complete CDER 09/13/2013
Mirabegron Use In progress CDER 10/11/2017
Niacin and Niacin Combination Products, Fenofibrates, and Omega-3 Products In progress CDER 10/12/2017
Hip Implant Procedures and Diagnoses 2 Complete CDER 01/07/2013
Incident Use of Testosterone Products Among All Members and Members with Pre-Existing Testosterone Use Complete CDER 06/03/2016
Osteoporotic Fractures following Lupron Depot-PED Use: A Multiple Factor Matched Analysis In progress CDER 07/02/2019
Hip Implant Procedures and Diagnoses Complete CDER 05/11/2012
Progressive Multifocal Leukoencephalapathy Complete CDER 02/24/2015
Top Ten Causes of Death Complete CDER 03/29/2018
Injection Gammagard Use Complete CDER 06/04/2014
Use of Tumor Necrosis Factor (TNF) Blocker Drugs In progress CDER 01/26/2018
Propylthiouracil and Methimazole Use 2 Complete CDER 10/07/2013
Sodium/Glucose Cotransporter (SGLT2) Inhibitors- Type 1 and Type 2 Diabetes Cohort Identification Complete CDER 10/30/2017
Occurrence of Selected Generic Drugs 6 Complete CDER 01/07/2013
Concomitant Use of Niacin and Statins and Concomitant Use of Fenofibrates and Statins Complete CDER 06/03/2016
New Users of Oral Bisphosphonates Complete CDER 05/08/2019
Long Acting Beta2-Agonists (LABA) Policies and Drug Utilization Patterns Complete CDER 01/09/2014
Injection Omalizumab Procedure Codes Complete CDER 02/25/2015
Warfarin Use Followed by International Normalized Ratio (INR) Lab Codes Complete CDER 04/02/2018
Hemorrhagic Disorder Diagnoses Complete CDER 06/04/2014
Counts of Commonly used Angiostensin-Converting Enzyme (ACE) Inhibitors and Beta Blockers In progress CDER 01/29/2018
Unspecified Anterior Pituitary Hyperfunction and Hypertrophy of the Breast Diagnoses Complete CDER 10/07/2013
Antipsychotics and Stroke Complete CDER 11/01/2017
Nucleoside Reverse Transcriptase Inhibitor Procedures Complete CDER 01/07/2013
Anticoagulant Use Among Members with Atrial Fibrillation and Various Pre-Existing Exlusions Complete CDER 05/27/2016
Use of Valsartan, Angiotensin II Receptor Blockers (ARB), and Angiotensin-Converting Enzyme (ACE) Inhibitors Complete CDER 06/05/2019
Negative Pressure Wound Therapy (NPWT) Procedures Complete CDER 06/08/2012
Omalizumab Use In progress CDER 02/25/2015
Clostridium difficile Infection Following Use of Vancomycin, Fidaxomicin, or Metronidzaole Complete CDER 04/03/2018
Immune Globulin Use Complete CDER 06/05/2014
Drug and Medical Enrollment Counts Complete CDER 01/29/2018
Occurrence of Selected Generic Drugs 9 Complete CDER 10/07/2013
Niacin and Fenofibrate Use and Outcomes with Propensity Score Matching Complete CDER 11/06/2017
Lindane Use Modular Program Complete CDER 01/10/2013
Anticoagulant Use Among Members with Pre-Existing Atrial Fibrillation and Various Pre-Existing Exclusions Complete CDER 05/25/2016
Use of Korlym and Mifeprex (Mifepristone) Complete CDER 06/24/2019
Clozapine Use Complete CDER 06/19/2012
Prevalent and Incident Use of Pramipexole In progress CDER 02/25/2015
Availability of International Normalized Ratio (INR) Laboratory Test Values and Test Procedures among Warfarin Users Complete CDER 04/03/2018
Antiepileptic Drug (AED) Injection Procedure Codes Complete CDER 01/31/2018
HIV and HBV Infection Diagnoses Complete CDER 10/07/2013
Stroke following Typical or Atypical Antipsychotic Use in Non-Elderly Patients: A Propensity Score Matched Analysis Complete CDER 11/02/2017
Bupropion and Naltrexone Use 2 Complete CDER 01/09/2013
Antidepressant Use and Bleeding Events Complete CDER 05/20/2016
Antiemetic Use During Pregnancy Complete CDER 06/24/2019
Use of Vascular Endothelial Growth Factor (VEGF) Inhibitors Complete CDER 06/19/2012
Hypoglycemic Events Following Use of Anti-Diabetic Agents (ADAs) Complete CDER 02/25/2015
Incident Use of Selective Serotonin Reuptake Inhibitor Antidepressants Complete CDER 05/21/2018